Cardio Balance the risk of cardiovascular diseases

Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot. Ektrak mula sa prutas ng cranberry Ektrak mula sa prutas ng appleberry Magnesium L-Arginin Ektrak mula sa dahon at bulaklak ng hawthorn Pulbos ng bulaklak ng hibiscus Ektrak mula sa dahon ng oliba Ektrak mula sa buto ng ubas Ektrak mula sa black currant Coenzyme Q10 Bitamina B6 Folate

Framingham scale for the assessment of the risk of cardiovascular diseases The Framingham heart study (engl. Framingham Heart Study), conducted since 1948 in the town of Framingham, Massachusetts (USA), is one of the most important long-term studies to investigate risk factors for cardiovascular disease (HKK). On the basis of this study, called the Framingham was developed scale — a tool for the quantitative evaluation of the individual 10‑year risk for cardiovascular events, especially heart attacks and strokes. Development and methodological foundations The scale is based on multi-variable statistical models, which have been validated in several cohorts of the Framingham study. The original models were initially developed for men and women separately and take into account the following main risk factors: Age (Years); Gender (male/female); Total cholesterol (mg/dL); HDL‑cholesterol (mg/dL, good cholesterol); Blood pressure (systolic value in mmHg, and treatment with antihypertensive medications); Smoking (Yes/no); Diabetes mellitus (Presence of disease). Application and Interpretation With the help of the Framingham scale, the 10‑year can be the risk of a patient for a first cardiovascular event (e.g. myocardial infarction, unstable Angina, stroke, coronary revascularization) in a percentage likelihood to convert. Usually, the following risk can be distinguished categories: low risk: <10%; medium risk: 10-20%; high risk: >20%. A risk score of >20% is considered to be an indication for intensified preventive therapy, including lipid-lowering drugs (statins) and blood pressure lowering drugs. Limitations and current developments Although the Framingham scale is globally widespread, it has some limitations: The models are based on data from a predominantly Caucasian population of the United States and can, therefore, deliver in other ethnic populations (e.g. Asian, African-American population) and the imprecise Risk estimates. The scale is not taken into account all of the modern risk markers such as C‑reactive Protein (CRP) or a family history of early cardiovascular disease. For younger persons (<40 years) is restricted to the validity of the scale, since the absolute risk probabilities are generally low, although the relative risk ratios of factors, such as Smoking and hypercholesterolaemia can be very high. Now therefore, alternative models have been developed, including the QRISK‑scales in the UK and the SCORE scale (Systematic COronary Risk Evaluation) in Europe, based in part on the modified Framingham approaches, however, additional factors to include. Conclusion The Framingham scale remains an important tool in cardiovascular prevention and serves as a scientific basis for many subsequent risk assessment models. Their application, however, requires a critical Interpretation, taking into account the population characteristics and individual risk profiles. A combined evaluation with modern biomarkers and family history can improve the Prädiktivität and a personalized prevention strategies. Would you like me to make a certain section in more detail or additional aspects to the Framingham scale add?

Ang presyon ng dugo ay isa sa mga pangunahing indikasyon ng kalusugan, na hindi lamang sumasalamin sa puso at sistema ng sirkulasyon, kundi pati na rin sa aktibidad ng mga bato, mga organo ng endokrin, paggawa ng dugo, at ng sistema ng nerbiyos. Kaya naman, walang isang unibersal na gamot laban sa mataas na presyon ng dugo. Hindi ka basta basta puwedeng pumunta sa botika at magtanong ng 'tableta para sa presyon,' kasi agad na tatanungin ng parmasyutiko – anong gamot ang nireseta sa iyo ng doktor? Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas.

Cardio Balance is formulated and made after years of rigorous research and clinical study of the ingredients. The unique combination of each ingredient brings out optimal effectiveness in supporting heart and blood pressure.
Cardio Balance the risk of cardiovascular diseases

Kung nagsimula na ang pag-inom ng gamot para sa mataas na presyon, hindi ibig sabihin na hindi na maaaring gawin ang karagdagang mga hakbang para palakasin ang katawan sa programa ng therapy. Ang benepisyo ng maingat na mga hakbang na pinagkasunduan ng doktor ay nakakatulong para mapigilan ang paglala ng sakit at maiwasang lumipat ito sa mas seryosong yugto.

Primary and secondary prevention of cardiovascular diseases Cardiovascular diseases (CVD) are one of the leading causes of death worldwide. Its prevention is therefore a key challenge for the health system. A distinction between primary and secondary prevention, which include different target groups and strategies. Primary Prevention Primary prevention aims cardiovascular disease is to prevent persons who have no clinical symptoms. It focuses on the modification of risk factors known to be associated with an increased risk of the disease are associated. Among the most important risk factors: arterial hypertension; Hyperlipidemia; Diabetes mellitus; Tobacco consumption; physical inactivity; unhealthy diet; Overweight and obesity; chronic Stress. Measures of primary prevention include: Health education and training: raising people's awareness of healthy lifestyles, prevention campaigns for Smoking abstinence and reduction of salt consumption. Behavior modification: the promotion of regular physical activity (at least 150 minutes of moderate activity per week), recommendations for a balanced diet (e.g., the DASH diet or Mediterranean diet). Drug interventions in high-risk patients: if necessary, administration of Lipid-lowering agents (statins) or antihypertensives in the case of individually balanced Benefit‑risk assessment. Secondary Prevention Secondary prevention concerns patients who have already had a cardiovascular disease (e.g., myocardial infarction, stroke, peripheral arterial disease). Your goal is the prevention of relapses and complications as well as improving the quality of life and life expectancy. Essential elements of secondary prevention are: Drug Therapy: Platelet aggregation inhibitors (e.g., acetylsalicylic acid); Beta-blockers after myocardial infarction; ACE inhibitors or AT1‑receptor blockers in heart failure or after myocardial infarction; Statins for lipid-lowering; Antihypertensive drugs to control blood pressure. Life style modifications: ongoing support in the case of Smoking, weight reduction, physical activity and diet. Cardiac Rehabilitation: a structured programs, the physical training sessions, psycho include social support and Patient education. Regular follow-up blood pressure, cholesterol and blood sugar monitoring and, if necessary, exercise ECG or imaging procedures. Conclusion Effective prevention of cardiovascular diseases requires an integrated approach that combines primary and secondary measures. While primary prevention is aimed at risk prevention, and focuses the secondary prevention on the optimization of the therapy and the reduction of recurrence risk. A close cooperation between family doctors, cardiologists, physical therapists, and nutritionists, as well as the active participation of the patient to the success of these strategies is crucial. Would you like me to make a certain section in more detail, or other aspects of complementary?

Punan ang form ng konsultasyon at order Cardio Balance the risk of cardiovascular diseases. Lilinawin ng operator ang lahat ng detalye sa iyo at ipapadala namin ang iyong order.

Cardio Balance the risk of cardiovascular diseases. Classification of cardiovascular diseases.